Abdominal aerobic endurance exercise
OtherSubjects combined treadmill running at 70% HRmax (27 minutes) with 4x4minutes (30-40% maximal strength, 1RM) of torso rotation and abdominal crunches (57 minutes), 4 days per wk for 10 weeks
NCT Number: NCT05794854
Spot reduction, referring to local body fat reduction, pertains to subcutaneous adipose tissue utilization from specific body parts during exercise. Its existence has been keenly debated, although generally accepted not to occur during exercise. However, it is based on not only equivocal data - commonly the training protocol typically applied is based on strength rather than endurance training. The investigators sought to test this assumption by utilizing endurance based exercise controlling for energy expenditure and using dual x-ray absorptiometric measures to assess body composition before and after training.
Looking for future studies?
Notify Me30 year–60 year
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects combined treadmill running at 70% HRmax (27 minutes) with 4x4minutes (30-40% maximal strength, 1RM) of torso rotation and abdominal crunches (57 minutes), 4 days per wk for 10 weeks
Subjects performed treadmill running (45 minutes) at 70% HRmax 4 days per week for 10 weeks
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Fat mass located in trunk (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Fat mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Fat mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Total fat mass (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Lean mass located in trunk (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Lean mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Lean mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Total lean mass (g) measured by dual-energy x-ray absorptiometry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
Maximal oxygen uptake by cardiopulmonary indirect calorimetry
Time frame: Change from pre (baseline) to post test (after 10 weeks)
One-repetition maximum (kg) in torso rotation and abdominal crunch
Molde University College
Other
The Assessment of Spot Reduction in Adults Males Following Endurance Training
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05207878
Healthy, Peripheral Nerve Injury Upper Limb
St Louis, Missouri, United States
View Trial DetailsNCT03876314
Alzheimer Disease, Behavior
Greensboro, North Carolina, United States
View Trial DetailsNCT07778186
Healthy, Nuclear Medicine Undergraduate Medical Education
Chengdu, Sichuan, China
View Trial DetailsNCT07778472
Healthy, Pathological Conditions, Signs and Symptoms
West Palm Beach, Florida, United States
View Trial Details